Inhibition of EZH2 and immune signaling exerts synergistic antitumor effects in chronic lymphocytic leukemia.

ABSTRACT:

SUBMITTER: Chartomatsidou E 

PROVIDER: S-EPMC6595263 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature